EP3793609
ORAL SOLUTION FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.5.2019EP published:
13.12.2023EP application number:
19731334.9
EPO information:
European Patent Register
Max expiry date:
2.5.2039
Title in English:
ORAL SOLUTION FORMULATIONLanguage of the patent:
English
Timeline
Today
3.5.2019EP application
13.12.2023EP Publication
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
JAIN, AshwinkumarAddress:
Groton, Connecticut 06340, US
Name:
YU, WeiliAddress:
Groton, Connecticut 06340, US
Priority
Number:
201862671208 PDate:
14.5.2018Country:
US
Number:
201962835278 PDate:
17.4.2019Country:
US
Classification
Categories:
A61K 47/12, A61K 47/18, A61K 9/00, A61K 47/26, A61K 31/519